A Globalized Model for Medical Affairs
How pharma companies can facilitate higher quality patient care at a lower cost.
Date : May 19, 2017
Pharmaceutical companies that have adopted a patient-centric approach have seen significant benefits in the form of greater patient adherence to medication, more consistent customer engagement, and overall improvements in the efficiency of their medical information and pharmacovigilance operations.
A Globalized Model for Medical Affairs

By: Anthony Chambers, Kaumil Dalal, and Matt Barnes

Through its critical role in communicating with patients and other stakeholders, the Medical Affairs function is at the center of the industry’s move toward patient centricity—yet the function’s current regional orientation could be at odds with this goal.

This white paper outlines three steps that pharmaceutical Medical Affairs functions should take to support a robust patient experience strategy and transform current operations into a global, integrated model. 

Read the paper to learn:

  • How the shift from a regional to globalized model for managing medical information can improve quality of care at a lower cost
  • How IT systems need to shift to support the new business model
  • What new technology is available to support the model
To read a full copy of our white paper, please complete the form below.
West Monroe Insights
Improving and Optimizing Cross Dock Operations
View More
Related Insights
Matt Barnes will present at Mergermarket’s Life Sciences and Healthcare M&A forum
Date : July 13, 2017 Time : 08:30 AM EST
Join West Monroe’s Matt Barnes at Mergermarket’s Life Sciences and Healthcare M&A forum as he discusses the science behind pharma mergers.
New York
Natural Language Generation Goes to Work
Date : January 24, 2017

Natural Language Generation (NLG) is a form of artificial intelligence (AI) which takes an input of data and produces a narrative similar to how a human would interpret the data. NLG technology can be very transformative when used in business situations, especially in industries that are heavily dependent on generating text summaries based on straightforward conclusions drawn from structured data and that lack the capital to support a large workforce.

Join West Monroe's Anthony Chambers for a webcast in partnership with Mergermarket, Citrix and BioPharm Insight
Date : June 10, 2016 Time : 02:00 PM EST
Experts speculate speculation that a raft of pharma consolidation can be expected this year as companies look to cut costs. Will this be the case? How can pharma companies deal with pressure from PBMs, insurers and the public?
New York